

22 May 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/05/22/3299923/0/en/storm-therapeutics-to-present-promising-phase-1-sarcoma-data-demonstrating-activity-of-first-in-class-mettl3-inhibitor-stc-15-at-asco-2026.html

08 Jan 2026
// PHARMIWEB
https://www.pharmiweb.com/press-release/2026-01-08/storm-therapeutics-and-alidabio-announce-strategic-collaboration-to-accelerate-development-of-cancer-therapies-targeting-rna-modifications